MedNation AGFRA:EIF 67 EBITDA Margin % is 11.69% as of Dec. 2025, which is 3% above its 10-year median of 11.38. GuruFocus rates FRA:EIF with a GF Score™ of 67/100 and a GF Value™ of €2.35 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 668 Healthcare Providers & Services companies, MedNation AG ranks worse than 50.45% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. MedNation AG's EBITDA for the
six
months ended in Dec. 2025 was €3.16 Mil. MedNation AG's Revenue for the
six
months ended in Dec. 2025 was €27.06 Mil. Therefore, MedNation AG's EBITDA margin for the quarter that ended in Dec. 2025 was 11.69%.
MedNation AG (FRA:EIF) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
MedNation AG EBITDA Margin % Related Terms
MedNation AG EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for MedNation AG's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:EIF vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, MedNation AG's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedNation AG EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MedNation AG's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where MedNation AG's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedNation AG (FRA:EIF) has a EBITDA Margin % of 11.69% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MedNation AG and its competitors. This is near median its historical median of 11.38. Over the past decade, MedNation AG's EBITDA Margin % has ranged from 4.85 to 19.13. According to the industry distribution chart, MedNation AG ranks #337 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 50.4%.
Is MedNation AG's EBITDA Margin % too high?
MedNation AG's current EBITDA Margin % of 11.69% is near median its 10-year median of 11.38. Over the past 10 years, this metric has ranged from a low of 4.85 to a high of 19.13. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. MedNation AG's value of 11.69% is 14.5% above this industry median. Based on the distribution chart, MedNation AG ranks #337 out of 668 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, MedNation AG has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MedNation AG's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, MedNation AG ranks #337 out of 668 companies for EBITDA Margin %. This places MedNation AG in the lower half of its industry. The industry median EBITDA Margin % is 10.21. MedNation AG's value of 11.69% is 14.5% above this benchmark. Historically, MedNation AG's own EBITDA Margin % has ranged from 4.85 to 19.13 over the past decade. While the company's 10-year median is 11.38 vs. the industry median of 10.21, MedNation AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedNation AG's current EBITDA Margin % of 11.69% is 14.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MedNation AG and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedNation AG's current EBITDA Margin % is 11.69%, which is near median its own 10-year median of 11.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedNation AG stock overvalued right now?
Based on GuruFocus' analysis, MedNation AG (FRA:EIF) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.35, compared to a current price of €4.00 — trading 70.2% above its estimated fair value. The current EBITDA Margin % is 11.69%, which is near median its 10-year median of 11.38 and 14.5% above the Healthcare Providers & Services industry median of 10.21. MedNation AG's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For MedNation AG (FRA:EIF), the current EBITDA Margin % is 11.69% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MedNation AG (FRA:EIF) Overvalued in 2026?
Based on GuruFocus' analysis, MedNation AG stock appears to be overvalued.
The current stock price of €4.00 is trading 70.2% above its estimated GF Value™ of €2.35.
GuruFocus considers MedNation AG to be Significantly Overvalued.
Key valuation signals for FRA:EIF:
EBITDA Margin %: 11.69% (near median its 10-year median of 11.38)
GF Value™: €2.35 vs. price of €4.00 (70.2% above fair value)
Industry Position: 14.5% above the Healthcare Providers & Services median (#337 of 668)
No single metric tells the full story. See the FRA:EIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MedNation AG operates rehabilitation hospitals. It has been operating facilities for rehabilitation, geriatric care and outpatient medical care at several locations for decades. The business purpose of MedNation AG also includes the development of independent outpatient centers as central, multidisciplinary medical centers to support freelance KV outpatient, specialist and medical-related care, especially in rural regions of Germany.
67GF Score
Get the complete analysis for FRA:EIF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:EIF has been successfully added to your 
